MedTrace Logo

Effect of Lactobacillus Paracasei PS23 on Improving Aging and Muscle Loss in the Elderly

NCT06062472 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 119

Last updated 2024-10-16

No results posted yet for this study

Summary

This study refers to the supplementation of PS23 in human experiments to help the elderly maintain muscle mass, delay muscle loss, promote physical activity, and delay the occurrence of disability and debilitation in elderly people.

Conditions

Interventions

DIETARY_SUPPLEMENT

Probiotics

Lactobacillus paracasei PS23 will be used in this study

DIETARY_SUPPLEMENT

heat-treated of Lactobacillus paracasei HT-PS23

heat-treated probiotic capsule contain 10 billion of Lactobacillus paracasei, 2 caps daily use

DIETARY_SUPPLEMENT

Placebo

The placebo capsule contains microcrystalline cellulose, 2 caps daily use

Sponsors & Collaborators

  • Bened Biomedical Co., Ltd.

    collaborator INDUSTRY

  • Chi-Chang Huang

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
65 Years
Max Age
85 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2023-08-08
Primary Completion
2023-11-30
Completion
2023-12-31

Countries

  • Taiwan

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06062472 on ClinicalTrials.gov